Olga Plotnikova Selected Research

T2384

4/2008

T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olga Plotnikova Research Topics

Disease

6	Neoplasms (Cancer) 10/2019 - 08/2013
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Reperfusion Injury 01/2018
1	Heart Arrest (Cardiac Arrest) 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Type 2 Diabetes Mellitus (MODY) 04/2008
1	Anemia 04/2008
1	Insulin Resistance 04/2008
1	Weight Gain 04/2008

Drug/Important Bio-Agent (IBA)

3	Phosphotransferases (Kinase)IBA 01/2016 - 09/2014
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Glutamine (L-Glutamine)FDA Link 10/2019
1	Alanine (L-Alanine)FDA Link 10/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2019
1	Serine (L-Serine)FDA Link 10/2019
1	Cysteine (L-Cysteine)FDA Link 10/2019
1	Pharmaceutical PreparationsIBA 04/2015
1	compound 18IBA 01/2015
1	Small Interfering RNA (siRNA)IBA 09/2014
1	Biological ProductsIBA 04/2008
1	LigandsIBA 04/2008
1	Rosiglitazone (Avandia)FDA Link 04/2008
1	T2384IBA 04/2008
1	PPAR gammaIBA 04/2008

Therapy/Procedure

3	Therapeutics 01/2015 - 08/2013
1	Precision Medicine 01/2020
1	Resuscitation 01/2018
1	Warm Ischemia 01/2018
1	Hemodilution 04/2008